Gel-Dispersed Nanostructures Lipid Carriers Loading Thymol Designed for Dermal Pathologies

Abstract

<p><strong style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Purpose:</strong><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> </span><em style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Acne vulgaris</em><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> is one of the most prevalent dermal disorders affecting skin health and appearance. To date, there is no effective cure for this pathology, and the majority of marketed formulations eliminate both healthy and pathological microbiota. Therefore, hereby we propose the encapsulation of an antimicrobial natural compound (thymol) loaded into lipid nanostructured systems to be topically used against acne.</span><strong style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Methods:</strong><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> To address this issue, nanostructured lipid carriers (NLC) capable of encapsulating thymol, a natural compound used for the treatment of acne vulgaris, were developed either using ultrasonication probe or high-pressure homogenization and optimized using 2</span><sup style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">2</sup><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">-star factorial design by analyzing the effect of NLC composition on their physicochemical parameters. These NLC were optimized using a design of experiments approach and were characterized using different physicochemical techniques. Moreover, short-term stability and cell viability using HaCat cells were assessed. Antimicrobial efficacy of the developed NLC was assessed in vitro and ex vivo.</span><strong style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Results:</strong><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> NLC encapsulating thymol were developed and optimized and demonstrated a prolonged thymol release. The formulation was dispersed in gels and a screening of several gels was carried out by studying their rheological properties and their skin retention abilities. From them, carbomer demonstrated the capacity to be highly retained in skin tissues, specifically in the epidermis and dermis layers. Moreover, antimicrobial assays against healthy and pathological skin pathogens demonstrated the therapeutic efficacy of thymol-loaded NLC gelling systems since NLC are more efficient in slowly reducing </span><em style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">C. acnes</em><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> viability, but they possess lower antimicrobial activity against </span><em style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">S. epidermidis</em><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">, compared to free thymol.</span><strong style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Conclusion:</strong><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> Thymol was successfully loaded into NLC and dispersed in gelling systems, demonstrating that it is a suitable candidate for topical administration against acne vulgaris by eradicating pathogenic bacteria while preserving the healthy skin microbiome.</span></p>